Contact  : +34 91 452 49 41 | firstname.lastname@example.org
Algenex is focused on the development and commercialization of remarkably productive, baculovirus based-technologies for manufacturing of high quality recombinant proteins.
Top-Bac: A proprietary expression cassette composed by several virus-derived regulatory elements that, when incorporated into the genome of baculovirus vector improves to unprecedented levels the productivity and quality of recombinant proteins produced by insect cells.
IBES: Based on the use of insect larvae as disposable, living biofactories that in combination with Top-Bac lead to record productivities for a baculovirus-based expression system.
Algenex key business lines are:
Licensing its proprietary technology platforms to produce recombinant proteins, whether for investigational or commercial purposes.
Co-development of vaccines with suitable partners.
Contract manufacturing to supply diagnostic reagents and/or assisting in their development.
ALGENEX was created to connect research and application as straightforwardly and time-efficiently as possible. We consider that helping underprivileged societies, through major cost reduction, to gain access to technological products that will improve their health and their economy, is our contribution to society.